Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3Neoplasms 2Stroke 1Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neuralgia 1Myocardial Infarction 1Liver Neoplasms 1Liver Cirrhosis 1Hot Flashes 1Hemorrhage 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Tranexamic Acid 13Sodium Chloride 4Misoprostol 4Saline Solution 3Enoxaparin 3carbetocin 2Tourniquets 2Ringer's Lactate 2Oxytocin 2Endoscopic Mucosal Resection 2Dalteparin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Vitamin B 6 1Vasopressins 1Uterine Myomectomy 1Uterine Artery Embolization 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Solution 1Radiotherapy 1Proton Pump Inhibitors 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemorrhage × Vitamin B 6 × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡